Sign In
Buy VERX
$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
Vertex Plunges Around 24% in Six Months: How to Play the Stock
10:31am, Wednesday, 17'th Sep 2025
Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.
1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals
07:30am, Monday, 15'th Sep 2025
Shares of Vertex Pharmaceuticals (VRTX -0.63%) have risen more than 2,000% over the past 20 years. Despite a terrific run-up, it's hard to find an investment bank analyst on Wall Street who expects th
Vertex Pharmaceuticals: Buying The CF Fortress For The Journavx Optionality
08:19am, Saturday, 13'th Sep 2025
Vertex Pharmaceuticals remains a buy, anchored by its dominant cystic fibrosis (CF) franchise and optionality in JOURNAVX. VRTX's near-term growth hinges on JOURNAVX's commercial ramp and pivotal diab
Vertex, Inc. (VERX) Presents At Goldman Sachs Communacopia + Technology Conference 2025 (Transcript)
03:22pm, Thursday, 11'th Sep 2025
Vertex, Inc. (NASDAQ:VERX ) Goldman Sachs Communacopia + Technology Conference 2025 September 11, 2025 12:30 PM EDT Company Participants David DeStefano - CEO, President & Chairman of the Board John S
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis
09:05am, Thursday, 11'th Sep 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year's Lasker~DeBakey
Calls of the Day: Abbvie, Vertex, Veeva and Vistra
01:47pm, Monday, 08'th Sep 2025
The Investment Committee discuss the latest Calls of the Day.
LA JOLLA, Calif.--(BUSINESS WIRE)-- #ADC--Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals.
Vertex Commerce Study: Off-Peak Shopping Trends Demand Smarter Tax Tech for Retailers
08:00am, Tuesday, 26'th Aug 2025
As 85% of consumers begin summer shopping in late winter, businesses face a new peak season – and a growing need for automated tax technology to manage product complexity and compliance As 85% of co
Vertex to Participate in Upcoming September Investor Conferences
04:00pm, Wednesday, 20'th Aug 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Susie Lisa, Senior Vice President, Investor
What's Wrong With Vertex Pharmaceuticals Stock?
04:14am, Wednesday, 20'th Aug 2025
Vertex Pharmaceuticals (VRTX 0.17%) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth oppor
Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More
09:01am, Monday, 18'th Aug 2025
This week's Undercovered Dozen spotlights 12 lesser-known stocks and ETFs, offering unique investment opportunities across gold, biotech, income, and tech sectors. B2Gold and Vertex Pharmaceuticals st
Vertex Inc.: Moving To The Sidelines As Near-Term Growth Expectations Get Reset
06:50am, Friday, 15'th Aug 2025
I downgrade Vertex (VERX) to Hold due to macro headwinds and ERP migration delays impacting near-term growth outlook. Cloud momentum and e-invoicing adoption remain strong, but on-premise weakness and
Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet
02:34pm, Tuesday, 12'th Aug 2025
A 20% drop in Vertex Pharmaceuticals' stock price since I wrote last month was the impetus to make a re-assessment. But the rating has remained unchanged at Hold. This is despite significantly improve
Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade)
04:47pm, Monday, 11'th Aug 2025
The recent Vertex Pharmaceuticals Incorporated stock drop after VX-993 trial results is overblown; the pain franchise remains robust with multiple promising avenues and ongoing trials. Vertex's CF fra
Vertex, Inc. (VERX) Q2 2025 Earnings Call Transcript
12:33pm, Wednesday, 06'th Aug 2025
Vertex, Inc. (NASDAQ:VERX ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants David DeStefano - CEO, President & Chairman of the Board John R. Schwab - Chief Financial Of
